Reduced purine nucleoside phosphorylase activity in preparations of enriched T-lymphocytes from patients with systemic lupus erythematosus.
D000328:Adult; D000974:Antibodies, Antinuclear; D001168:Arthritis / Q000201:enzymology; D001665:Binding Sites; D004247:DNA / Q000276:immunology; D003956:Dialysis; D005260:Female; D006454:Hemoglobins; D006801:Humans; D007958:Leukocyte Count; D008180:Lupus Erythematosus, Systemic / Q000201:enzymology* / Q000276:immunology; D008214:Lymphocytes; D008297:Male; D008875:Middle Aged; D010430:Pentosyltransferases / Q000378:metabolism*; D011565:Psoriasis / Q000201:enzymology; D011683:Purine-Nucleoside Phosphorylase / Q000378:metabolism*; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000201:enzymology*
D000974:Antibodies, Antinuclear; D006454:Hemoglobins; D004247:DNA; D010430:Pentosyltransferases; D011683:Purine-Nucleoside Phosphorylase